article thumbnail

Radicle Science and Open Book Extracts Announce New Alliance to Advance Consumer Trust and CBD Industry Validation

Cannabis Law Report

The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development. About Open Book Extracts. To learn more about the Radicle Science-OBX alliance, read The Movement Is On! About Radicle Science.

article thumbnail

How Medical Marijuana Is Changing Lives with Crohn’s Disease

LifeCannMD

This shift towards cannabis-based therapies is reshaping the landscape of Crohn’s management, offering new hope and improved quality of life for patients who have long struggled with the disease’s debilitating symptoms. Cannabis has analgesic properties that help alleviate abdominal cramps and discomfort.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the Current Legal Status of Psychedelics in the United States

Cannabis Law Report

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Though, Oregon is actively in the process of establishing a model for psilocybin that would be like the state’s current medical cannabis system. Schedule I.

article thumbnail

These Patient Advocacy Groups Are Working Together to Expand the Scope of Cannabis Research

Veriheal

With new and improved products popping up left and right, legalization initiatives taking off all over the globe, and harmful “stoner” stigmas quickly dissipating, it’s clear that cannabis has entered a new era. The days of “reefer madness” are long over, replaced by a growing acknowledgment of the cannabis plant’s therapeutic abilities.

article thumbnail

Synergetic Press and MAPS Form Copublishing Partnership

Cannabis Law Report

As with MAPS, Synergetic Press has been a leading publisher of cutting-edge books in the field of psychedelics and consciousness. We are proud to bring the groundbreaking books from MAPS into our ever-expanding catalog.”. Today, he and his team have succeeded at getting very far down that road.

Therapy 90
article thumbnail

Press Release: Canada – Princeton mushroom research and development facility officially opens, sells first grow of psilocybin mushrooms

Cannabis Law Report

The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m We have other deals on the books already,” Henderson said. “It’s The team has been focused on creating an environment that can be perfectly controlled for production.

article thumbnail

Press Release: Nue Life announces donations to Multidisciplinary Association for Psychedelic Studies and Ketamine Research Foundation

Cannabis Law Report

MAPS is sponsoring the most advanced psychedelic therapy research in the world: Phase 3 clinical trials of MDMA-assisted therapy for PTSD. “We are proud to support the profound research of these organizations,” continued Mr.